Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dronedarone Strategies in Elective Cardioversion for AF
NCT01026090Phase 4Terminated
- Sponsor
- Sanofi
- Start
- Nov 2009
- Primary completion
- Dec 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of dronedarone in Atrial fibrillation (AFib), sponsored by Sanofi. Started Nov 2009; status: terminated.
02
Drugs
dronedarone
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT01026090.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01026090.